Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2–10 Years
Conclusions: One incident EOI of asthma late in the 1-year observation period and sporadic distribution of SMAEs were observed. These data do not suggest safety concerns associated with MenACWY-CRM vaccination in children 2–10 years old.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Vaccine Reports Source Type: research
More News: Asthma | Children | Clinical Trials | Electronic Health Records (EHR) | Emergency Medicine | Infectious Diseases | Italy Health | Men | Meningitis | Meningitis Vaccine | Myasthenia Gravis | Pediatrics | Poisoning | Statistics | Study | Typhoid | Typhoid Vaccine | USA Health | Vaccines